4-己基苯甲酰氯 | 50606-95-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酰卤
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-己基苯甲酰氯
• 中文别名: 4-正己苯甲酰氯
• 英文名称: 4-hexylbenzoyl chloride
• 英文别名: 4-n-hexylbenzoyl chloride；p-n-hexylbenzoyl chloride；para-n-hexyl benzoic acid chloride
• CAS: 50606-95-6
• 化学式: C₁₃H₁₇ClO
• mdl: MFCD00000701
• 分子量: 224.73
• InChiKey: XRAHLPNMIIAEPP-UHFFFAOYSA-N

物化性质

• 沸点：
  176-177°C 22mm
• 密度：
  1.029 g/mL at 25 °C (lit.)
• 闪点：
  >230 °F
• 稳定性/保质期：
  如果按照规定使用和储存，则不会发生分解，目前没有发现已知的危险反应。

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.461
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• TSCA：
  Yes
• 危险等级：
  8
• 危险品标志：
  C
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• WGK Germany：
  3
• 海关编码：
  2916399090
• 包装等级：
  II
• 危险类别：
  8
• 危险品运输编号：
  UN 3265 8/PG 2
• 储存条件：
  请将贮藏器密封保存，并存放在阴凉干燥处。同时，确保工作环境具有良好的通风或排气设施。

SDS

Name:	4-Hexylbenzoyl chloride 99% Material Safety Data Sheet
Synonym:	Benzoyl chloride, 4-hexyl
CAS:	50606-95-6

Section 1 - Chemical Product MSDS Name:4-Hexylbenzoyl chloride 99% Material Safety Data Sheet
Synonym:Benzoyl chloride, 4-hexyl

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
50606-95-6	Benzoyl chloride, 4-hexyl-	99	256-647-6

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes gastrointestinal tract burns. May cause perforation of the digestive tract. May cause systemic effects.
Inhalation:
May cause severe irritation of the respiratory tract with sore throat, coughing, shortness of breath and delayed lung edema. Causes chemical burns to the respiratory tract. Aspiration may lead to pulmonary edema. May cause systemic effects.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Do NOT allow victim to rub eyes or keep eyes closed.
Extensive irrigation with water is required (at least 30 minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do not use mouth-to-mouth resuscitation if victim ingested or inhaled the substance; induce artificial respiration with the aid of a pocket mask equipped with a one-way valve or other proper respiratory medical device.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Water hydrolyzes material liberating acidic gas which in contact with metal surfaces can generate flammable and/or explosive hydrogen gas.
Extinguishing Media:
DO NOT USE WATER! Do NOT get water inside containers. In case of fire, use carbon dioxide, dry chemical powder or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation. Do not get water inside containers.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Do not get in eyes, on skin, or on clothing. Do not ingest or inhale. Do not allow contact with water. Use only in a chemical fume hood. Discard contaminated shoes. Keep from contact with moist air and steam.
Storage:
Store in a tightly closed container. Store protected from moisture.
Store in a cool, dry area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 50606-95-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear yellow
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Hydrolysis.
Specific Gravity/Density: 1.0290g/cm3
Molecular Formula: C13H17ClO
Molecular Weight: 224.73

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. May decompose on exposure to moist air or water.
Conditions to Avoid:
Incompatible materials, moisture, contact with water.
Incompatibilities with Other Materials:
Moisture, water, alcohols, oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, phosgene, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 50606-95-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Benzoyl chloride, 4-hexyl- - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, N.O.S.*
Hazard Class: 8
UN Number: 1760
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing group: II

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
WGK (Water Danger/Protection)
CAS# 50606-95-6: No information available.
Canada
CAS# 50606-95-6 is listed on Canada's NDSL List.
CAS# 50606-95-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 50606-95-6 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-己基苯甲酰氯 在 palladium on activated charcoal 三正丁胺 、 氢气 作用下， 以 苯 为溶剂， 反应 6.0h， 生成 4-N-己基苯甲醛
  参考文献：
  名称：

  直链4-烷基苯甲醛的合成

  摘要：

  描述了通过不同方法制备不含位置和支链异构体的直链4-烷基苯甲醛的方法。报道了醛的一步制备，其涉及在Pd / C催化剂存在下将Friedel Craft's配合物直接氢化。

  DOI：

  10.1002/hlca.19820650810
• 作为产物：
  描述：

  苯己酮 在 三乙基硅烷 、 aluminum (III) chloride 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 48.5h， 生成 4-己基苯甲酰氯
  参考文献：
  名称：

  苄基嘧啶衍生物、其制备方法及其医药用途

  摘要：

  本发明涉及药物化学领域，具体涉及一类嘧啶类衍生物（I）、它们的制备方法、含有这些化合物的药用组合物以及它们的医药用途，特别是作为免疫抑制剂在自身免疫性疾病方面和器官移植方面的用途。

  公开号：

  CN103408501B

文献信息

• [EN] ALKYNYL ARYL CARBOXAMIDES<br/>[FR] ALKYNYLARYL-CARBOXAMIDES
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2005012280A1

  公开（公告）日：2005-02-10

  The present invention is related to alkynyl aryl carboxamides of Formula (I’) and use thereof for the treatment and/or prevention of an inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance. insulin resistance, hyperlipidemia, hypertriglyceridemia- hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of alkynyl aryl carboxamides of Formula (I’) to modulate, notably to inhibit the activity of PTPs. (I’) A is a C2-C15 alkynyl, C2-C6-alkynyl aryl, C2-C6-alkynyl heteroaryl. Cy is an aryl, heteroaryl, cycloalkyl or heterocycle group; n is either 0 or 1. Cy' is an aryl., which may optionally be fused by a 3-8 membered cycloalkyl. R1and R2 are independently from each other is selected from the group consisting of hydrogen or (CI-C6)alkyl. R4and R5 are each independently from each other selected from the group consisting of H, hydroxy. C1 -C6 alkyl, carboxy, C1-C6 alkoxy, C1 -C3 alkyl carboxy, C2-C3 alkenyl carboxy, C2-C3 alkynyl carboxy, amino or R4 and R5 may form an unsaturated or saturated heterocyclic ring, whereby at least one of R4 or R5 is not a hydrogen or C1-C6 alkyl.

  本发明涉及式(I')的炔基芳基羧酰胺及其用于治疗和/或预防由胰岛素抵抗或高血糖介导的炎症疾病、肥胖和/或代谢紊乱的使用，包括I型和/或II型糖尿病、葡萄糖耐量不足、胰岛素抵抗、高脂血症、高甘油三酯血症-高胆固醇血症、多囊卵巢综合征(PCOS)。特别是，本发明涉及使用式(I')的炔基芳基羧酰胺来调节，尤其是抑制PTPs的活性。(I') A是C2-C15炔基，C2-C6-炔基芳基，C2-C6-炔基杂芳基。Cy是芳基、杂芳基、环烷基或杂环族；n是0或1。Cy'是一个芳基，它可以选择性地通过一个3-8成员的环烷基融合。R1和R2独立地互选自由氢或(C1-C6)烷基组成的组。R4和R5各自独立地互选自H、羟基。C1-C6烷基、羧基、C1-C6烷氧基、C1-C3烷基羧基、C2-C3烯基羧基、C2-C3炔基羧基、氨基或R4和R5可以形成一个不饱和或饱和的杂环，其中至少R4或R5不是氢或C1-C6烷基。
• MEDICINAL COMPOSITIONS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1402900A1

  公开（公告）日：2004-03-31

  The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.

  本发明涉及一种用于预防或治疗疼痛的药剂，一种用于抑制破骨细胞活化的药剂，以及一种包含p38 MAP激酶抑制剂和/或TNF-α产生抑制剂的破骨细胞形成抑制剂。
• CONCOMITANT DRUGS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1354603A1

  公开（公告）日：2003-10-22

  The present invention relates to a pharmaceutical agent containing one or more kinds of a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor and one or more kinds of drugs selected from the group consisting of (1) a non-steroidal antiinflammatory drug, (2) a disease-modifying anti-rheumatic drug, (3) an anti-cytokine drug, (4) an immunomodulator, (5) a steroid and (6) a c-Jun N-terminal kinase inhibitor in combination. This combination agent is useful as a prophylactic or therapeutic agent of the diseases such as rheumatism, arthritis and the like, and other diseases.

  本发明涉及一种含有一种或多种p38 MAP激酶抑制剂和/或TNF-α产生抑制剂以及从（1）非甾体抗炎药、（2）疾病修饰性抗风湿药、（3）抗细胞因子药物、（4）免疫调节剂、（5）类固醇和（6）c-Jun N末端激酶抑制剂中选择的一种或多种药物的药物制剂。这种组合药剂可用作预防或治疗风湿病、关节炎等疾病以及其他疾病的药物。
• Copper-Catalyzed Selective <i>ortho</i>-C–H/N–H Annulation of Benzamides with Arynes: Synthesis of Phenanthridinone Alkaloids
  作者：Ting-Yu Zhang、Jun-Bing Lin、Quan-Zhe Li、Jun-Chen Kang、Jin-Long Pan、Si-Hua Hou、Chao Chen、Shu-Yu Zhang

  DOI：10.1021/acs.orglett.7b00442

  日期：2017.4.7

  convenient copper-catalyzed method has been developed to achieve direct ortho-C–H/N-H annulation to synthesize phenanthridinones with arynes. This method highlights an emerging strategy to transform inert C–H bonds into versatile functional groups in organic synthesis and provides a new way to synthesize phenanthridinone alkaloids efficiently.

  已经开发出一种有效且方便的铜催化方法，以实现直接邻位-C-H / NH环化反应，以合成具有芳烃的菲啶酮。该方法突显了一种新兴的策略，可将惰性C–H键转变为有机合成中的多功能官能团，并为有效合成菲啶酮类生物碱提供了新途径。
• Mesomorphic compound, liquid crystal composition containing same, liquid
  申请人：Canon Kabushiki Kaisha

  公开号：US05595685A1

  公开（公告）日：1997-01-21

  A mesomorphic compound represented by: ##STR1## where R.sub.1 and R.sub.2 are alkyl; X.sub.1 and X.sub.3 are a single bond, ##STR2## X.sub.2 is a single bond, ##STR3## A.sub.1, A.sub.2 and A.sub.3 are a single bond, aryl, heteroaryl, pyrimidyl or cyclohexyl, X.sub.4a, X.sub.5a, X.sub.4b, X.sub.5b, X.sub.4c and X.sub.5c are H, F, Cl, Br, --CH.sub.3, --CN or --CF.sub.3 ; and n is 0 or 1.

  一个由以下结构表示的中间化合物：##STR1## 其中 R.sub.1 和 R.sub.2 是烷基；X.sub.1 和 X.sub.3 是单键，##STR2## X.sub.2 是单键，##STR3## A.sub.1、A.sub.2 和 A.sub.3 是单键，芳基，杂环芳基，嘧啶基或环己基，X.sub.4a、X.sub.5a、X.sub.4b、X.sub.5b、X.sub.4c 和 X.sub.5c 是 H、F、Cl、Br、--CH.sub.3、--CN 或 --CF.sub.3；n 为 0 或 1。